Back to Newsroom

Axovant Announces Changes to Board of Directors

BASEL, Switzerland, June 6, 2017 /PRNewswire/ — Axovant Sciences (NYSE: AXON) today announced that it has appointed Patrick Machado to the Company’s Board of Directors effective as of June 15, 2017, while Lawrence Olanoff, MD, and Gary Pisano, Ph.D., have stepped down as directors effective as of the June 1, 2017 board meeting.